par Verbeelen, Dierik;Vanhaelst, Luc 
;Fuss, Michel ;Van Steirteghem, André
Référence Journal of endocrinological investigation, 8, 2, page (103-106)
Publication Publié, 1985
;Fuss, Michel ;Van Steirteghem, AndréRéférence Journal of endocrinological investigation, 8, 2, page (103-106)
Publication Publié, 1985
Article révisé par les pairs
| Résumé : | In normal man 1, 25 (OH)2-vitamin D3 [1, 25 (OH)2D] increases both basal and TRH-stimulated prolactinemia; this effect is completely reversible by the calcium antagonist nifedipine. Similarly the 1, 25 (OH)2D-induced hypercalcemia is totally inhibited by nifedipine. These findings suggest that both biological effects of 1, 25 (OH)2D are mediated by calcium-dependent mechanisms. © 1985, Italian Society of Endocrinology (SIE). All rights reserved. |
